ClinicalTrials.Veeva

Menu

Genicular Artery Embolization (GAE) vs inTra-articular Corticosteroid Injection for Osteoarthritic Knee Pain. (GET-IN)

National Taiwan University logo

National Taiwan University

Status

Terminated

Conditions

Osteoarthritis (OA) of the Knee

Treatments

Procedure: Genicular artery embolization
Procedure: Intra-articular injection with corticosteroids.

Study type

Interventional

Funder types

Other

Identifiers

NCT06929585
202408153RIND

Details and patient eligibility

About

This study investigates genicular artery embolization (GAE) as a minimally invasive alternative to ntra-articular corticosteroid injections (IA) or treating knee osteoarthritis (OA) pain. Designed as a randomized controlled tria, the study compares pain relief effectiveness and safety between GAE and IA over a 12-month follow-up. Eligible participants are aged over 40 with symptomatic knee OA resistant to conservative treatment. Primary outcomes focus on pain reduction (NRS score), while secondary measures include function, quality of life, imaging findings, and adverse events.

Enrollment

1 patient

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age ≥ 40 years
  2. Symptomatic knee pain, with numeric rating scale (NRS) ≥ 4.
  3. Insufficient or resistant to conservative treatment, including oral analgesics, physical therapy, intra-articular injections for at least 3 months, before the enrollment.
  4. Weight bearing X ray of knee: osteoarthritis of Kellgren-Lawrence grade 1, 2, or 3.

Exclusion criteria

  1. History of trauma in recent 6 months.
  2. Bleeding tendency.
  3. Poor renal function (serum creatinine > 2.0 mg/dL).
  4. Pregnancy or breast-feeding.
  5. Severe peripheral arterial occlusive disease (PAOD).
  6. Local infections or inflammatory arthritis of knee.
  7. Rheumatoid arthritis or other rheumatological diseases.
  8. Prior knee surgeries (arthroscopic surgery, menisci repair, cruciate ligament reconstruction, arthroplasty of knee) due to knee pain.
  9. Malignancy
  10. ECOG > grade 2
  11. Life expectancy less than 2 years.
  12. Any other condition related to the patient's health, regarded exclusionary in the opinion of the investigator.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

1 participants in 2 patient groups

Experimental arm: GAE (IPM/CS).
Experimental group
Description:
Genicular artery embolization with imipenem/cilastatin (IPM/CS).
Treatment:
Procedure: Genicular artery embolization
Comparator: IA (corticosteroids)
Active Comparator group
Description:
The patient will receive IA procedure and sham GAE procedure.
Treatment:
Procedure: Intra-articular injection with corticosteroids.

Trial contacts and locations

1

Loading...

Central trial contact

Yu-Chen Wang, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems